Q1 Scientific expands its European operations from Wallonia

Q1 Scientific, a Cambrex company and a leading provider of ICH-compliant stability storage and GDP-certified pharmaceutical storage services, has announced a significant expansion of its operations in Wallonia with an additional 4,000 m².

This investment marks a major milestone for Q1 Scientific’s activities in Villers-le-Bouillet and reflects Cambrex’s ongoing strategic commitment to developing life sciences infrastructure and capabilities in key regions worldwide.

The additional 4,000 m² includes temperature-controlled stability storage areas, GDP storage, and modern office space, significantly increasing Q1 Scientific’s capacity to support the rapidly growing European pharmaceutical, biotechnology, and clinical research sectors.

“This expansion represents a major step forward for Q1 Scientific in Belgium and for the life sciences community in Wallonia. With an additional 4,000 m², we are significantly increasing our capacity to support clinical and commercial supply chains with high-quality, GDP-compliant storage solutions,” comments Cécile Jacoby, Managing Director of Q1 Scientific SRL in Villers-le-Bouillet.

The expansion strengthens Q1 Scientific’s ability to support both clinical trials and commercial manufacturers by adding substantial GDP-certified storage capacity for investigational medicinal products and finished pharmaceuticals.

Products destined for hospitals, pharmacies, and distributors in Belgium and across continental Europe will now benefit from increased capacity for secure, compliant, and fully temperature-controlled storage.

With purpose-built storage chambers ranging from -80°C to +40°C, the expanded site will enable long-term, accelerated, and intermediate stability studies, as well as secure commercial storage and disaster recovery services for emergency situations.

“Q1 Scientific continues to invest in Belgium due to the exceptional quality of talent, strong logistics infrastructure, and the dynamism of the life sciences sector. This expansion demonstrates our long-term commitment to the region and our confidence in the future of our operations in Belgium. By increasing our stability and GDP storage capacity, we are strengthening our ability to support global pharmaceutical companies with reliable, compliant, and scalable solutions exactly where they are needed,” concludes Stephen Delaney, Managing Director of the Q1 Scientific Group.

Isabelle Anneet (AWEX)